Peter Jianrui Liu is a physician, scientist, and Forbes recognized entrepreneur with over 15 years of experience in research translation and innovation, with a particular focus on oncology and diagnostic technologies. His journey spans four continents, having worked at the World Health Organization, led the Oxford University Scientific Society, and founded an international innovation think tank. As the Founder and Founding CEO of the series A stage company Oxford Cancer Analytics, he raised over $20 million in investment and grant funding to develop novel minimally invasive blood tests for cancer detection, starting from lung cancer. He holds a MD from the University of Toronto and a PhD (DPhil) in Clinical Medicine from the University of Oxford.